Background: Few randomized trials have compared bioprostheses for transcatheter aortic valve replacement, and no trials have compared bioprostheses with supra-annular design. The SCOPE 2 trial (Safety and Efficacy Comparison of Two TAVI Systems in a Prospective Randomized Evaluation 2) was designed ...
Highlights, strengths & weaknesses, commercial applications, and societal impact — written for this paper on demand.
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!